Seminars in Ultrasound, CT and MRI
Volume 27, Issue 5 , Pages 420-425, October 2006

The Role of 18F-FDG PET/CT in the Evaluation of Solid Splenic Masses

  • Ur Metser, MD

      Affiliations

    • Corresponding Author InformationAddress reprints requests to: Ur Metser, MD, Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizman Street, Tel-Aviv, 64239 Israel.
    • ,
  • Einat Even-Sapir, MD, PhD

Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

18F-Fluorodeoxyglucose–positron emission tomography/computed tomography is a noninvasive imaging modality that appears to have a high negative-predictive value for malignancy in assessing solid splenic masses discovered on conventional imaging modalities. Histological sampling is recommended for fluorodeoxyglucose-avid splenic masses, as the main differential diagnosis includes malignancy, either primary or secondary, or granulomatous disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-2171(06)00058-8

doi:10.1053/j.sult.2006.06.005

Seminars in Ultrasound, CT and MRI
Volume 27, Issue 5 , Pages 420-425, October 2006

Article Tools

* Image Usage & Resolution